Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Shares Issued: 2009-2025

Historic Shares Issued for Northwest Biotherapeutics (NWBO) over the last 16 years, with Sep 2025 value amounting to $4.9 million.

  • Northwest Biotherapeutics' Shares Issued fell 31.66% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 million, marking a year-over-year increase of 112.34%. This contributed to the annual value of $14.2 million for FY2024, which is 728.01% up from last year.
  • Per Northwest Biotherapeutics' latest filing, its Shares Issued stood at $4.9 million for Q3 2025, which was down 33.57% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, Northwest Biotherapeutics' Shares Issued ranged from a high of $8.0 million in Q3 2021 and a low of $32,000 during Q3 2023.
  • For the 3-year period, Northwest Biotherapeutics' Shares Issued averaged around $3.0 million, with its median value being $1.6 million (2024).
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 94.65% in 2022, then spiked by 22,131.25% in 2024.
  • Quarterly analysis of 5 years shows Northwest Biotherapeutics' Shares Issued stood at $7.9 million in 2021, then tumbled by 85.82% to $1.1 million in 2022, then crashed by 89.37% to $119,000 in 2023, then soared by 3,434.45% to $4.2 million in 2024, then crashed by 31.66% to $4.9 million in 2025.
  • Its last three reported values are $4.9 million in Q3 2025, $7.3 million for Q2 2025, and $5.1 million during Q1 2025.